Reaction SMILES: CCN(C(C)C)C(C)C.C1CN([P+](ON2N=NC3C=CC=CC2=3)(N2CCCC2)N2CCCC2)CC1.F[P-](F)(F)(F)(F)F.[C:43]([O:47][C:48]([NH:50][C:51]1[S:55][C:54]([C:56]2[C:61]([F:62])=[CH:60][CH:59]=[CH:58][C:57]=2[F:63])=[N:53][C:52]=1[C:64]([OH:66])=O)=[O:49])([CH3:46])([CH3:45])[CH3:44].[NH2:67][C:68]1[CH:69]=[N:70][N:71]([CH3:82])[C:72]=1[N:73]1[CH2:79][CH2:78][CH2:77][C:76]([CH3:81])([OH:80])[CH2:75][CH2:74]1>C(Cl)Cl.O>[F:62][C:61]1[CH:60]=[CH:59][CH:58]=[C:57]([F:63])[C:56]=1[C:54]1[S:55][C:51]([NH:50][C:48](=[O:49])[O:47][C:43]([CH3:44])([CH3:45])[CH3:46])=[C:52]([C:64](=[O:66])[NH:67][C:68]2[CH:69]=[N:70][N:71]([CH3:82])[C:72]=2[N:73]2[CH2:79][CH2:78][CH2:77][C:76]([OH:80])([CH3:81])[CH2:75][CH2:74]2)[N:53]=1
Reactant: CC(C)(C)OC(=O)Nc1sc(-c2c(F)cccc2F)nc1C(=O)O
Reactant: Cn1ncc(N)c1N1CCCC(C)(O)CC1
Agent: F[P-](F)(F)(F)(F)F
Agent: c1ccc2c(c1)nnn2O[P+](N1CCCC1)(N1CCCC1)N1CCCC1
Solvent: CCN(C(C)C)C(C)C
Solvent: ClCCl
Solvent: O
Product: Cn1ncc(NC(=O)c2nc(-c3c(F)cccc3F)sc2NC(=O)OC(C)(C)C)c1N1CCCC(C)(O)CC1
Temperature: 25 °C
Reaction time: 16 h
Yield: 92.3 %

Procedure:
To a solution of 4-methyl-1-(1-methyl-4-nitro-1H-pyrazol-5-yl)azepan-4-ol (212 mg, 0.83 mmol) and ammonium formate (386 mg, 6.6 mmol) in MeOH (15 mL) under nitrogen was added 10% palladium on carbon (88 mg, 0.83 mmol). The mixture was heated at 80° C. for 16 hr before being cooled, filtered through Celite® and concentrated under reduced pressure. The residue was partitioned between water (20 mL) and DCM (40 mL) and the organic layer was separated, passed through a phase separation cartridge and concentrated under reduced pressure to give 1-(4-amino-1-methyl-1H-pyrazol-5-yl)-4-methylazepan-4-ol as a red oil which was used without further purification. To a solution of DIPEA (0.06 mL, 0.33 mmol), PyBOP (151 mg, 0.29 mmol) and 5-(tert-butoxycarbonylamino)-2-(2,6-difluorophenyl)-thiazole-4-carboxylic acid (89 mg, 0.25 mmol) in DCM (10 mL) (pre-stirred for 30 min) was added 1-(4-amino-1-methyl-1H-pyrazol-5-yl)-4-methylazepan-4-ol (47 mg, 0.21 mmol) and the mixture was stirred at room temperature for 16 hr. The mixture was diluted with DCM (30 mL) and water (20 mL). The organic layer was passed through a phase separation cartridge and the solvent removed under reduced pressure. Purification via silica gel column chromatography (0-100% EtOAc/isohexane) gave tert-butyl 2-(2,6-difluorophenyl)-4-(5-(4-hydroxy-4-methylazepan-1-yl)-1-methyl-1H-pyrazol-4-ylcarbamoyl)thiazol-5-ylcarbamate as an off-white solid (109 mg). This solid was stirred with HCl in 1,4-dioxane (4 M, 5 mL, 20 mmol) in MeOH (5 mL) at room temperature for 16 h. The solvent was removed under reduced pressure, the residue re-dissolved in MeOH and passed through an SCX column, washing with DCM and MeOH and eluting with 3-10% 7 N ammonia in MeOH/DCM. Purification via silica gel column chromatography (0-5% MeOH/DCM) gave 146 as an off-white solid (36 mg, 37% over 3 steps). 1H NMR (400 MHz, d4-MeOD) δ 7.68 (s, 1H), 7.52-7.43 (m, 1H), 7.17-7.10 (m, 2H), 3.74 (s, 3H), 3.56-3.44 (m, 1H), 3.19-3.10 (m, 1H), 3.04-2.96 (m, 1H), 2.14-2.02 (m, 1H), 1.94-1.80 (m, 4H), 1.74-1.64 (m, 1H), 1.23 (s, 3H) (1 proton coincident with solvent peak). LCMS (ES+) m/z 463 (M+1).